Functional analysis of the top ERBB2-correlated genes (e.g., MED24) suggested that overexpression of MED24, a subunit of the Mediator complex, might be required for the ERBB2 pathway to dysregulate gene expression and the consequent lung cancer development. This evidence concerns the gene ERBB2 and lung carcinoma.